|
Volumn 107, Issue 6, 2001, Pages 1039-1045
|
Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma
a a a a b b b c b |
Author keywords
Airway inflammation; APC 366; Asthma; Bronchial hyperresponsiveness; Early asthmatic response; Late asthmatic response; Mast cell; Tryptase
|
Indexed keywords
ALLERGEN;
HISTAMINE;
N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE;
TRYPTASE;
ADULT;
AEROSOL;
ALLERGIC ASTHMA;
AREA UNDER THE CURVE;
ARTICLE;
BRONCHUS HYPERREACTIVITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EFFICACY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
FEMALE;
HUMAN;
MALE;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
PROVOCATION TEST;
RANDOMIZED CONTROLLED TRIAL;
SHORT COURSE THERAPY;
|
EID: 0035013541
PISSN: 00916749
EISSN: None
Source Type: Journal
DOI: 10.1067/mai.2001.115631 Document Type: Article |
Times cited : (135)
|
References (38)
|